Mitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC)

Clinical trial NCT00452387 · TERMINATED

Trial details

NCT number: NCT00452387
Sponsor: Accelerated Community Oncology Research Network
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Prostate Cancer

Start date: 2007-05-01
Primary completion: 2008-07-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.